Biotest AG-Product Pipeline Review-2015

Biotest AG-Product Pipeline Review-2015

  • Products Id :- GMDHC07062CDB
  • |
  • Pages: 40
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Biotest AG-Product Pipeline Review-2015


Global Markets Direct's, 'Biotest AG-Product Pipeline Review-2015', provides an overview of the Biotest AG's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Biotest AG's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


The report provides brief overview of Biotest AG including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Biotest AG's human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Biotest AG's pipeline products

Reasons To Buy

Evaluate Biotest AG's strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Biotest AG in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Biotest AG's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Biotest AG and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Biotest AG

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Biotest AG and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Biotest AG Snapshot 5

Biotest AG Overview 5

Key Information 5

Key Facts 5

Biotest AG-Research and Development Overview 6

Key Therapeutic Areas 6

Biotest AG-Pipeline Review 8

Pipeline Products by Stage of Development 8

Pipeline Products-Monotherapy 9

Pipeline Products-Partnered Products 10

Partnered Products/Combination Treatment Modalities 11

Biotest AG-Pipeline Products Glance 12

Biotest AG-Late Stage Pipeline Products 12

Phase III Products/Combination Treatment Modalities 12

Biotest AG-Clinical Stage Pipeline Products 13

Phase II Products/Combination Treatment Modalities 13

Phase I Products/Combination Treatment Modalities 14

Biotest AG-Early Stage Pipeline Products 15

Preclinical Products/Combination Treatment Modalities 15

Biotest AG-Drug Profiles 16

BT-094 16

Product Description 16

Mechanism of Action 16

R&D Progress 16

hepatitis C virus immune globulin (human) 17

Product Description 17

Mechanism of Action 17

R&D Progress 17

BT-086 19

Product Description 19

Mechanism of Action 19

R&D Progress 19

indatuximab ravtansine 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

tregalizumab 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

fibrinogen concentrate (human) 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

BT-063 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

Biotest AG-Pipeline Analysis 26

Biotest AG-Pipeline Products by Target 26

Biotest AG-Pipeline Products by Route of Administration 27

Biotest AG-Pipeline Products by Molecule Type 28

Biotest AG-Pipeline Products by Mechanism of Action 29

Biotest AG-Recent Pipeline Updates 30

Biotest AG-Dormant Projects 33

Biotest AG-Company Statement 34

Biotest AG-Locations And Subsidiaries 36

Head Office 36

Other Locations & Subsidiaries 36

Biotest AG-Key Manufacturing Facilities 38

Appendix 39

Methodology 39

Coverage 39

Secondary Research 39

Primary Research 39

Expert Panel Validation 39

Contact Us 39

Disclaimer 40

List of Tables

Biotest AG, Key Information 5

Biotest AG, Key Facts 5

Biotest AG-Pipeline by Indication, 2015 7

Biotest AG-Pipeline by Stage of Development, 2015 8

Biotest AG-Monotherapy Products in Pipeline, 2015 9

Biotest AG-Partnered Products in Pipeline, 2015 10

Biotest AG-Partnered Products/ Combination Treatment Modalities, 2015 11

Biotest AG-Phase III, 2015 12

Biotest AG-Phase II, 2015 13

Biotest AG-Phase I, 2015 14

Biotest AG-Preclinical, 2015 15

Biotest AG-Pipeline by Target, 2015 26

Biotest AG-Pipeline by Route of Administration, 2015 27

Biotest AG-Pipeline by Molecule Type, 2015 28

Biotest AG-Pipeline Products by Mechanism of Action, 2015 29

Biotest AG-Recent Pipeline Updates, 2015 30

Biotest AG-Dormant Developmental Projects,2015 33

Biotest AG, Subsidiaries 36

Biotest AG, Key Manufacturing Facilities 38

List of Figures

Biotest AG-Pipeline by Top 10 Indication, 2015 7

Biotest AG-Pipeline by Stage of Development, 2015 8

Biotest AG-Monotherapy Products in Pipeline, 2015 9

Biotest AG-Pipeline by Top 10 Target, 2015 26

Biotest AG-Pipeline by Top 10 Route of Administration, 2015 27

Biotest AG-Pipeline by Top 10 Molecule Type, 2015 28

Biotest AG-Pipeline Products by Top 10 Mechanism of Action, 2015 29

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]

Current R&D Portfolio of Biotest AG; Biotest AG - Key Therapeutics; Biotest AG - Pipeline Overview and Promising Molecules; Biotest AG - News; Biotest AG - Latest Updates; Biotest AG - Pipeline; Biotest AG - Discontinued/Dormant Projects

select a license

Single User License
USD 1500 INR 101595
Site License
USD 3000 INR 203190
Corporate User License
USD 4500 INR 304785



Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]